We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
The Baby Room is an independent luxury online retailer of furniture, nursery goods, designer clothing and footwear for babies and children. The company has 12,000 e-mail subscribers, 4,300 Facebook Likes, £260 Average Basket Value, and 26% repeat customers. Moreover, the company has tier 1 relationships with Versace, Fendi, Moschino, and Silver Cross. The Baby Room has achieved a new 1st-year turnover of £4.7M and £101K net profit, achieving a 15 fold increase in turnover (2018-19). With the proceeds, the company will enhance its infrastructure and team.
days to go: Expired investment: £22,080
Wild & Stone (W&S) is on a mission to make sustainable and stylish items the natural alternatives to commonly used plastics with products like bamboo toothbrushes and reusable steel razors. W&S stresses that its products carry a 30-day no-quibble returns policy, and for every order, it donates to the Marine Conservation Society. W&S argues that it has completed over 100,000 orders, grown its range to include over 85 products, and earned over £850,000 in revenue since its launch. It also points out that it is listed on major marketplaces including, Amazon, NOTHS, Wayfair, eBay, and Etsy. W&S products have been nominated for multiple Amazon choice awards. Its founder, Kathryn Jonas, was shortlisted for the 'Sustainability Entrepreneur of the Year, Southeast region' at the Great British Entrepreneur Awards 2021. The company has featured in publications such as Vogue, The Times, Tatler, Elle, and The Independent. They state they will use the investment to increase its product range and level of inventory.
days to go: Expired investment: £250,460
A new form of electric transport in the bike industry with the use of an affordable and simple conversion kit. Swytch have developed a kinetically rechargeable add-on for existing bikes to convert them into eBikes for a range of up to 50 miles. Funding will result in additional units being manufactured and sold at a 70% margin. The products are available online and currently via 20 independent bike dealers, with over 100 more waiting on stock.
days to go: Expired investment: £349,356
PLAYin CHOC is an innovative, premium and award-winning manufacturer of vegan organic eco-friendly toys and chocolates. Its products are allergen-free, plastic-free, 100% organic and inspire creative play. Since its launch, PLAYin CHOC has sold approximately 50,000+ units in 21 countries. Additionally, potential stockists for its products are estimated at 100,000 in the UK and 1 million globally. Now, PLAYin CHOC is planning to take its product to the market via high-end food supermarkets; independent food, confectionary and gift shops; travel retail market; direct to the consumer via subscription; and international distributors. Funds raised will be used to increase growth by securing larger and permanent premises and intensify targeted marketing at trade & consumer shows and online.
days to go: Expired investment: £278,450
Receive an affordable massage at home and on-demand by easily booking straight from an app. Since the start of year, Urban Massage has delivered more than 114,000 massages and received a 4.85/5 or above rating for the level of treatment provided to their customers. The company has successfully launched in Birmingham, Manchester and Paris with an Annualised Run Rate (ARR) of 3,300% from June 2014 and in June 2018, an ARR of £10.4m.
days to go: Expired investment: £3,491,730
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go: Expired investment: £165,627
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph